In8bio

INAB

INAB In8bio NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    INAB Chart
    See on advanced chart >

    About

    In8bio, Inc. was incorporated in Bermuda on February 8, 2016. On May 7, 2018, the company reincorporated in the United States in a domestication transaction in which it converted into a newly formed Delaware corporation, the company is a clinical-stage...
    • Highlight
      A clinical-stage biopharmaceutical company that focused on gamma-delta T cell product candidates for solid and liquid tumors
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      07/30/2021
    • Established Date
      05/07/2018
    • Full-time Employees
      31
    • Address
      350 5th Avenue Suite 5330 New York New York 10118
    • Tel
      1-646-6006438
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-04-23 10:54:07